Immunogenicity and Safety of Tetanus, Diphtheria and Mono Component Acellular Pertussis (TdaP) Vaccine in Comparison to Tetanus and Diphtheria (Td) Vaccine When Given as Booster Vaccinations to Adults
Clinical trial NCT01033877 · COMPLETED
Trial details
- NCT number
- NCT01033877
- Sponsor
- Statens Serum Institut
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-01
- Primary completion
- 2010-08-01
- Enrollment
- 802
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.